PNEUMOVAX
MERCK
Identification
- Active ingredient (INN)
- VACCIN PNEUMOCOCCIQUE POLYOSIDIQUE
- Internal code
- 13 U 506
- Country of Origin
- France
- Pharmaceutical form
- IM Injectable Solution (Pre-filled Syringe)
- Prescription List
- OTC
- Packaging
- boite de 01 seringue preremplie de 0.5ml avec 02 aiguilles et boite de 10
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Pneumococcal vaccine is used to prevent pneumococcal bacteria infection, which leads to pneumonia.
Blood poisoning.
Associated Conditions
One of the most important warnings is the use of pneumocococcal vaccine: the CDC recommends that the second dose after 5 years be for patients suffering from chronic kidney failure, HIV infection, cancer, or spleenlessness.
Mechanism of Action
Vaccination vaccine (Pneumoccal Vaccination vaccine), also called Pneumoccal Pneumoccal Vaccination vaccine (Pneumoccus Pneumoniae Bacterium), which causes many serious pneumoccus infections such as pneumonia, meningitis, blood poisoning and other dangerous infections that, at worst, may lead to brain damage and may be fatal.
The first
Pneumonia vaccine was developed in the 1980s and is now on the WHO list of essential medicines required in the health system for its effectiveness.
PPSV23 for the prevention of 23 different strains of pneumonia vaccine (PV13) is currently available.